Search research articles
Contact Us
Filters
Showing results (121-130 of 207) with videos related to
Page
of 21
Sort By:
Journal of Extracellular Vesicles
|
July 19, 2017
Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells
Xiaohua Zhu, Mohamed Badawi, Steven Pomeroy, et al.
Mabs
|
March 6, 2014
Ocaratuzumab, an Fc-engineered antibody demonstrates enhanced antibody-dependent cell-mediated cytotoxicity in chronic lymphocytic leukemia
Carolyn M Cheney, Deborah M Stephens, Xiaokui Mo, et al.
Radiology
|
May 5, 2017
MR Elastography-derived Stiffness: A Biomarker for Intervertebral Disc Degeneration
Benjamin A Walter, Prasath Mageswaran, Xiaokui Mo, et al.
The Journal of Biological Chemistry
|
December 3, 2015
Analysis of the Effects of the Bruton's tyrosine kinase (Btk) Inhibitor Ibrutinib on Monocyte Fcγ Receptor (FcγR) Function
Li Ren, Amanda Campbell, Huiqing Fang, et al.
Stem Cells (Dayton, Ohio)
|
February 14, 2013
MELK-dependent FOXM1 phosphorylation is essential for proliferation of glioma stem cells
Kaushal Joshi, Yeshavanth Banasavadi-Siddegowda, Xiaokui Mo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2012
Milatuzumab-conjugated liposomes as targeted dexamethasone carriers for therapeutic delivery in CD74+ B-cell malignancies
Yicheng Mao, Georgia Triantafillou, Erin Hertlein, et al.
Oncotarget
|
March 9, 2018
Polo-like kinase inhibitor volasertib marginally enhances the efficacy of the novel Fc-engineered anti-CD33 antibody BI 836858 in acute myeloid leukemia
Bhavani Gopalakrishnan, Carolyn Cheney, Rajeswaran Mani, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 22, 2022
Disruption of Nurse-like Cell Differentiation as a Therapeutic Strategy for Chronic Lymphocytic Leukemia
Giovanna Merchand-Reyes, Ramasamy Santhanam, Frank H Robledo-Avila, et al.
Oncoimmunology
|
October 21, 2016
Targeting myeloid-derived suppressor cells using a novel adenosine monophosphate-activated protein kinase (AMPK) activator
Prashant Trikha, Robert L Plews, Andrew Stiff, et al.
Metabolites
|
July 25, 2019
Metabolic Regulation of Glycolysis and AMP Activated Protein Kinase Pathways during Black Raspberry-Mediated Oral Cancer Chemoprevention
Thomas J Knobloch, Nathan M Ryan, Lei Bruschweiler-Li, et al.
Page
of 21
Search research articles
Search
Showing results (121-130 of 207) with videos related to
Sort By:
Page
of 21
Journal of Extracellular Vesicles
|
July 19, 2017
Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells
Xiaohua Zhu, Mohamed Badawi, Steven Pomeroy, et al.
Mabs
|
March 6, 2014
Ocaratuzumab, an Fc-engineered antibody demonstrates enhanced antibody-dependent cell-mediated cytotoxicity in chronic lymphocytic leukemia
Carolyn M Cheney, Deborah M Stephens, Xiaokui Mo, et al.
Radiology
|
May 5, 2017
MR Elastography-derived Stiffness: A Biomarker for Intervertebral Disc Degeneration
Benjamin A Walter, Prasath Mageswaran, Xiaokui Mo, et al.
The Journal of Biological Chemistry
|
December 3, 2015
Analysis of the Effects of the Bruton's tyrosine kinase (Btk) Inhibitor Ibrutinib on Monocyte Fcγ Receptor (FcγR) Function
Li Ren, Amanda Campbell, Huiqing Fang, et al.
Stem Cells (Dayton, Ohio)
|
February 14, 2013
MELK-dependent FOXM1 phosphorylation is essential for proliferation of glioma stem cells
Kaushal Joshi, Yeshavanth Banasavadi-Siddegowda, Xiaokui Mo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2012
Milatuzumab-conjugated liposomes as targeted dexamethasone carriers for therapeutic delivery in CD74+ B-cell malignancies
Yicheng Mao, Georgia Triantafillou, Erin Hertlein, et al.
Oncotarget
|
March 9, 2018
Polo-like kinase inhibitor volasertib marginally enhances the efficacy of the novel Fc-engineered anti-CD33 antibody BI 836858 in acute myeloid leukemia
Bhavani Gopalakrishnan, Carolyn Cheney, Rajeswaran Mani, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 22, 2022
Disruption of Nurse-like Cell Differentiation as a Therapeutic Strategy for Chronic Lymphocytic Leukemia
Giovanna Merchand-Reyes, Ramasamy Santhanam, Frank H Robledo-Avila, et al.
Oncoimmunology
|
October 21, 2016
Targeting myeloid-derived suppressor cells using a novel adenosine monophosphate-activated protein kinase (AMPK) activator
Prashant Trikha, Robert L Plews, Andrew Stiff, et al.
Metabolites
|
July 25, 2019
Metabolic Regulation of Glycolysis and AMP Activated Protein Kinase Pathways during Black Raspberry-Mediated Oral Cancer Chemoprevention
Thomas J Knobloch, Nathan M Ryan, Lei Bruschweiler-Li, et al.
Page
of 21